Competitive Intelligence (CI), Competitive Intelligence Services

Competitive Intelligence (CI)

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Thelansis support both scientific and business team in understanding the Competitive environment, Market unmet need and opportunities, Emerging Technology and potential risk, Regulatory and Market access scenario, distribution network, and essentially the insights around competitor marketing strategy. Data points from primary and secondary research further follow a strict sense check process; extraction, cleaning, validation, triangulation, and storyboarding.

At Thelansis, “quality and client satisfaction” is the paramount objective and has been transformed into our working methods over time. Integration of the right talent pool and the defined process could essentially bring operational excellence as a critical indicator of the success of any business.

Its Competitive intelligence services process creates a virtual technology-driven environment to collate critical insights and real-world data evidence in real-time. Essential information could be captured based on data points on Market Landscapes, Product and company profiling, Clinical trial benchmarking, healthcare conferences, and primary CI feeders from or in-house panel management system.

Key opinion leaders (KOLs) across the value chain, such as; Clinical Practitioners, Researchers, Industry experts, regulatory bodies, regional and national payers, and essentially the channel partners, are critical sources of information that have great relevance based on their expertise and experiences. Thelansis’s panel management system integrates critical stakeholders into the virtual platform to provide real-world cross-functional industry insights into specific business questions.

Competitive intelligence process integration

Nevertheless, the “Thelansis KOL validation” process suggests the three most important things clients need to know 3 “R” principle – REMAIN, REMOVE, REFRESH – to make a list of KOL up-to-date and entirely align to your strategic business needs. When you know your KOLs well, all you may need is an unbiased sense-check to quickly and efficiently validate your current list. Never to overlook, when a KOL has been in a therapy area for a while, they may get used to working with the same people repeatedly. So, they don’t always see the changes happening just outside their field – the myopia of over-confidence and over-familiarity creeps in. That’s where “Thelansis KOL validation” can provide seamless support.

Thelansis understand the importance of data security policy and protocol compliance to avoid illegal acts or misuse of client data. Our data security personnel performs regular audits to mitigate any misconduct or threats related to data protection. However, our employees have undergone relevant training programs of a minimum of 40 hours per year on applicable laws, guidelines, and standard operating procedures to comply with data security policy.

EXPLORE MEDIA

OTHER LINKS

REACH US

Sales office
US: +1 (267) 244-6955
Delivery Office
India: +91 (124)-4041731

clientsupport@thelansis.com

Pankaj Negi

Head – Business Development and Partnering

Mr. Pankaj Negi has joined Thelansis as Practice Head; Business Development and Partnering, since Jan 2020. A dynamic professional with 12+ years of diverse experience across Pharmaceuticals/ Healthcare/ Life sciences with specialized in sales & marketing and Business Development.

Mr. Pankaj is holding a Master’s degree in “Pharma Management” from the Rajiv Gandhi University of Health Science, Bangalore, India and has expertise in Content Marketing, Content Management systems, Customer Relationship Management, online marketing, advertising, promotion, and Search Engine Optimization. Creating and implementing client-centered, successful campaigns, aimed at improving brand awareness and presence.

Mukesh Kumar

Vice President – Delivery, Scientific CI

Mukesh Kumar has joined us as Vice President – Delivery & Innovations, Scientific CI Practice, since August 2019. Prior to joining us, Dr. Mukesh holding a Postdoctoral Fellow with a demonstrated history of working in hard-core research for more than 15 years on both small molecule and biologics within the oncology and neurology segment.

Skilled in Recombinant DNA, Phage Display Technology, Antibodies, ImmunoOncology (K-RAS, Check-Point, Oncolytic), and Immunotherapeutic (RNA andProtein/huMab-based) products, Cancer-stem Cells, Chemoresistance, Real-TimePolymerase Chain Reaction (qPCR), and SDS-PAGE. Strong research professional with a Ph.D. focused on Recombinant Antibody-mediated tumor targeting. Dr.Mukesh has several citations on Synergistic increase in efficacy of a combination of 2-deoxy-D-glucose and cisplatin in normoxia and hypoxia: switch from autophagy to apoptosis, Membrane, Fusion Mediated Targeted Cytosolic DrugDelivery Through scFv Engineered Sendai Viral Envelopes, and Drug combination targeting hypoxia-induced chemoresistance and stemness in glioma cells.

Peeyush Potdar

Director – Practice Head, Competitive Intelligence, Market Access, and Pricing

Mr. Peeyush Potdar is working at Thelansis as Practice Head; Competitive Intelligence, Market Access, and Pricing Analytics, since Dec 2017. With 12+ years of rich experience in providing business consulting and research support across competitive intelligence, BD&L activities, KOL management, business research, and analytics services, he has been involved in the development of syndicated therapy area specialized reports in Orphan & ultra-orphan indications and conducting market intelligence assignments on different verticals such as Pharmaceuticals, Medical Devices and Health Insurance.

Mr. Peeyush is holding an MBA degree in “Pharma Management” from the National Institute of Pharmaceutical Education & Research (NIPER), Mohali, India and has expertise in scientific research as well as in commercialization and lifecycle management for innovative and mature assets. He has a good competency in building AI/ ML-based analytics platforms for tracking global conferences, social media analytics, and for conducting patient outcomes research.

Martina Berg

Director – Global Relationship and Partnering US

Ms. Martina is working with us as Director – Global Relationship and Partnering US, since October 2019. Prior to joining us, Ms. Martina holding a Master’s Degree in Public Health from Boston University School of Public Health with more than 8 years of experience in B2B and B2C sales. Highly motivated and accomplished sales and marketing professional with a proven history of success in creating the road map and driving business development globally.

Part of US Leadership team and heading Business Development for Thelansis Knowledge Partner for both US and EU Region. Business Development opportunity identification, Engaging with the client and providing them with innovative business solutions.